Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Open Label Trial of rIL-2 and Bevacizumab Combination in Patients With Metastatic Clear Cell Renal Carcinoma

NCT00853021 is registered in ClinicalTrials.gov with Jorge A. Garcia, MD as lead sponsor.

NCT NCT00853021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00853021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Open Label Trial of rIL-2 and Bevacizumab Combination in Patients With Metastatic Clear Cell Renal Carcinoma
Lead sponsor
Jorge A. Garcia, MD
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
October 31, 2009
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer